help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, S. B.
Right arrow Articles by Arnold, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, S. B.
Right arrow Articles by Arnold, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 2 868-872
Copyright © 2000 by The Endocrine Society

Original Studies

Vitamin D Receptor as a Candidate Tumor-Suppressor Gene in Severe Hyperparathyroidism of Uremia1

Suzanne B. Brown, Tamika T. Brierley, Nallasivam Palanisamy, Isidro B. Salusky, William Goodman, Maria Luisa Brandi, Tilman B. Drüeke, Emile Sarfati, Pablo Ureña, R. S. K. Chaganti, J. Wesley Pike and Andrew Arnold

Center for Molecular Medicine and Division of Endocrinology and Metabolism, University of Connecticut School of Medicine (S.B.B., T.T.B., A.A.), Farmington, Connecticut 06030-3101; Memorial Sloan-Kettering Cancer Center (N.P., R.S.K.C.), New York, New York 10021; University of California Medical Center (I.S., W.G.), Los Angeles, California 90095; University of Florence (M.L.B.), 50139 Florence, Italy; Hôpital Necker (T.B.D., P.U.), 75743 Paris, France; Hôpital St. Louis (E.S.), 75475 Paris, France; and University of Cincinnati (J.W.P), Cincinnati, Ohio 45267

Address all correspondence and requests for reprints to: Dr. Andrew Arnold, Center for Molecular Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030-3101.

Most chronic renal failure patients with severe refractory hyperparathyroidism harbor at least one monoclonal parathyroid tumor, but the specific acquired genetic defects that confer this clonal selective advantage remain poorly understood. Somatic inactivation of the vitamin D receptor (VDR) gene could contribute to clonal outgrowth, because a parathyroid cell containing this lesion would have an impaired response to the antiproliferative influence of 1,25-dihydroxyvitamin D3. Furthermore, diminished expression of VDR protein has been described in uremia-associated parathyroid tumors. Therefore, to assess VDR gene inactivation’s potential pathogenetic role in this disease, we rigorously analyzed the VDR gene in 59 parathyroid tumors surgically resected from uremic patients.

First, Southern blotting and/or PCR analyses of 29 tumor samples from 14 genetically informative patients revealed no allelic losses at the VDR locus. Next, direct DNA sequencing of all VDR splice junctions, associated intronic sequences, and virtually the entire VDR-coding region for all 59 tumors revealed no acquired mutations. Last, 37 tumor DNA samples were subjected to comparative genomic hybridization, and no chromosomal losses in the VDR region (12cen-q12) were observed.

These observations suggest that inactivating defects within the VDR gene do not commonly contribute to the primary pathogenesis of severe refractory hyperparathyroidism in uremia.




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Hibi, F. Kambe, Y. Tominaga, Y. Mizuno, H. Kobayashi, K. Iwase, T. Imai, and H. Seo
Up-Regulation of the Gene Encoding Protein Kinase A Type I{alpha} Regulatory Subunit in Nodular Hyperplasia of Parathyroid Glands in Patients with Chronic Renal Failure
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 563 - 568.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Fukagawa, J. J. Kazama, and T. Shigematsu
Management of patients with advanced secondary hyperparathyroidism: the Japanese approach
Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1553 - 1557.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Canaff and G. N. Hendy
Human Calcium-sensing Receptor Gene. VITAMIN D RESPONSE ELEMENTS IN PROMOTERS P1 AND P2 CONFER TRANSCRIPTIONAL RESPONSIVENESS TO 1,25-DIHYDROXYVITAMIN D
J. Biol. Chem., August 9, 2002; 277(33): 30337 - 30350.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Imanishi, H. Tahara, N. Palanisamy, S. Spitalny, I. B. Salusky, W. Goodman, M. L. Brandi, T. B. Drueke, E. Sarfati, P. Urena, et al.
Clonal Chromosomal Defects in the Molecular Pathogenesis of Refractory Hyperparathyroidism of Uremia
J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1490 - 1498.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. J. Marx
Hyperparathyroid and Hypoparathyroid Disorders
N. Engl. J. Med., December 21, 2000; 343(25): 1863 - 1875.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society